← All indications
Biological Availability
The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (1)
Phase 2 trials (4)
Phase 1 trials (76)
- diclofenac
- fluticasone
- methylprednisolone
- acalabrutinib
- oxandrolone
- atovaquone
- sorafenib
- Eliapixant
- darolutamide
- mirabegron
- ketamine
- dexlansoprazole
- doxylamine
- dsm265
- cannabidiol
- filgotinib
- gemfibrozil
- ethinyl estradiol
- naltrexone
- ritonavir
- rifampin
- famotidine
- palonosetron
- icosapent ethyl
- hyaluronidase (human recombinant)
- belumosudil
- drospirenone
- dronabinol
- megestrol
- desogestrel
- +46 more
Other trials (31)
- efavirenz
- iron
- capsaicin
- fiber
- fluorodopa
- hydroxytyrosol
- krill oil
- menaquinone
- vitamin c
- orange juice
- cow milk
- pterostilbene
- immune globulin (human)
- collagen
- aronia extract
- coffee
- inactivated influenza vaccine
- oleanolic acid
- soybean
- methylfolate
- turmeric
- 5-methyl-tetrahydrofolate
- fish oil
- cherry
- blueberry
- hesperidin
- iron sulfate
- ferrous sulfate
- epicatechin
- fermented aronia
- +1 more